T he molecular mechanisms regulating the expression of CIITA have been the subject of intense research by immunologists for more than a decade because it encodes a transcriptional coactivator that functions as the 'master regulator' of the expression of major histocompatibility complex class II genes [1] [2] [3] . The results reported in this issue by Ni et al. 4 bring to light a new and unanticipated complexity in the regulation of interferon-γ (IFN-γ)-induced CIITA expression by showing that it involves a series of five distant enhancers that promote the formation of a complex and dynamic threedimensional chromatin structure.
It is now well established that transcription of CIITA is regulated by several promoters 2, 3, 5 . Four promoters, pI, pII, pIII and pIV, have been defined in human CIITA (Fig. 1) . Each of these promoters is responsible for distinct tissue-specific expression modes of CIITA 2, 3 . The promoters pI and pIII are responsible for myeloid-and lymphoid-specific expression patterns, respectively 6 . The specific function of pII is not yet known. The promoter pIV is the main IFN-γ-responsive promoter functioning in nonhematopoietic cells 7 . The finding that triggered the studies of Ni et al. 4 was that reporter gene constructs driven by the known regulatory sequences of pIV do not show dependency on BRG1, an ATP-dependent chromatin-remodeling factor shown before to be required for IFN-γ-induced expression of endogenous CIITA 8, 9 . This prompted a search for distant BRG1-
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CIITA encodes the 'master regulator' of the expression of major histocompatibility complex class II genes. A new layer of complexity has been identified in the control of CIITA expression, which involves the formation of a complex three-dimensional chromatin structure promoted by interactions among many distant regulatory elements. dependent enhancers required for IFN-γ-induced activation of pIV.
To pinpoint candidate enhancers, the authors first did chromatin-immunoprecipitation analysis and chromatin immunoprecipitation coupled to microarrays 4 . They used these approaches to identify regions in the CIITA locus that have IFN-γ-induced histone modifications associated with gene activation (acetylation of histones H3 and H4; methylation of lysine 4 of H3), that are associated with a histone acetyltransferase (p300) linked to IFN-γ-induced CIITA expression, and/or that are bound by transcription factors (STAT1 and IRF1) known to mediate IFNγ-induced CIITA expression 10 . They have identified five candidate enhancers spread over a 110-kilobase region encompassing the entire CIITA gene (Fig. 1) . To show that these five regions indeed function as transcriptional enhancers required for IFN-γ-induced CIITA expression, they have done an impressive series of functional experiments with an elegant and sophisticated reporter gene system that relies on the engineering and transfection of bacterial artificial chromosome constructs containing 194 kilobases of genomic DNA from the CIITA locus. Finally, they use the chromatin conformation capture approach to demonstrate that the newly identified distal enhancers engage in many long-distance interactions with each other and with pIV to generate a complex and dynamic three-dimensional chromatin structure. The results suggest that in noninduced cells or in the absence of BRG1, the longdistance chromatin interactions are weak, transient or present in only a fraction of the cells (Fig. 1) . However, the presence of BRG1 and/or exposure of the cells to IFN-γ promotes stabilization and remodeling of the three-dimensional structure (Fig. 1) . Remodeling of the chromatin structure seems to be a requirement for CIITA expression. 
Figure 1
The CIITA locus and its four promoters, pI, pII, pIII and pIV. The thicker cyan line represents the entire CIITA gene from pI through to its last exon. Orange globes indicate the relative locations of the newly identified BRG1-dependent distal enhancers that collectively regulate IFN-γ-induced expression through pIV. In the uninduced state, weak or transient interactions between several of the enhancers and pIV occur. After IFN-γ induction, the interactions between the enhancers, and between the enhancers and pIV, are stabilized to form a discrete structure required for CIITA expression. The gene encoding dexamethasone-induced transcript (Dex1) is adjacent to the 3′ end of CIITA. Positions below CIITA are numbered in kilobases relative to pIV.
N E W S A N D v I E W S
Until now, the individual promoters of the CIITA gene were believed to function as independent units and therefore have generally been presented as separate 'boxes' arrayed along a linear DNA molecule (Fig. 1, top line) . However, the results reported by Ni et al. 4 now show that this one-dimensional and promotercentric view of the regulatory region of CIITA needs to be revised. It is evident from their work that full understanding of the complexity of CIITA gene regulation must integrate the establishment and function of longdistance and dynamic chromatin interactions between regulatory elements that can be situated more than 100 kilobases apart. This view is becoming more common with genes that, like CIITA, were once thought to be regulated exclusively by their promoter-proximal regulatory regions 11, 12 . Examples of these include the major histocompatibility complex class II genes that CIITA regulates, for which CIITA itself participates in long-range interactions with insulator-binding factors 13 .
Future research will probably concentrate on the establishment and function of chromatin structures at the CIITA locus. In IFN-γ-induced CIITA expression, many important questions remain. At the top of the list are questions about the precise function of BRG1: does it move the nucleosomes to allow STAT1 and IRF1 binding or are other proteins involved? At present, the identity of the proteins that mediate the establishment of the long-distance chromatin loops between the distal enhancers and pIV remains unknown. Although such long-distance loops are indeed formed and required, it is not apparent why the proximal promoter regulatory elements at pIV are not sufficient for activation. One possibility suggested by the data is that repressive mechanisms are at work to ensure that the region cannot be activated without the aid of the other enhancer elements. Finally, it will be imperative to determine whether the lessons learned from IFN-γ-induced cells are also relevant to the regulation of CIITA in key 'professional' antigen-presenting cells, including dendritic cells, macrophages and B cells, and in cortical and medulary thymic epithelial cells. Are three-dimensional chromatin structures also critical in regulating CIITA expression in antigen-presenting cells and thymic epithelial cells? Are the structures formed in these cells similar to or different from those linked to IFN-γ-induced cells? Are the same or different distal enhancers involved in different cell types? The answers to these questions will provide fascinating new insights into the molecular mechanisms that regulate CIITA expression and thereby control antigen presentation mediated by major histocompatibility complex class II. Progress in these directions will contribute to propelling the regulation of CIITA expression to the forefront of the mammalian gene-regulatory systems that have been delineated genetically and biochemically in the greatest detail. volume 9 number 7 july 2008 nature immunology T he transcription factor Erg has presented a challenging problem for researchers for over two decades since its discovery 1 . Strongly linked to the pathogenesis of many cancers and noteworthy in its expression pattern, in vitro transcriptional activity and genomic linkages, the Erg proto-oncogene has nevertheless resisted conventional reverse-genetic approaches for defining its normal functions in vivo. In this issue of Nature Immunology, Loughran et al. now report a considerable advance toward the clarification of this gene's importance 2 . Using the classic forward-genetics approach of a phenotypic screen on a 'sensitized background' (discussed below), these investigators have obtained a missense mutation of Erg that is probably the first lesion to cause a distinct loss of function of this transcription factor. This mutation turns out to have profound effects on definitive hematopoiesis and especially on the hematopoietic stem cell compartment. Erg gene dosage is shown to be so critical that a strong effect on stem cell function is present even in the heterozygous state.
Erg has long been suspected of being involved in self-renewal-associated proliferation because of its many contributions to cancer. Translocations that link the Erg DNAbinding domain to other genes or place Erg expression under inappropriate control are probably causal factors in Ewing's sarcoma and prostate cancer 3 , and aberrantly high Erg expression has been linked to hematopoietic cancers, including myeloid and T lymphoblastic leukemias. ERG maps to the Down's syndrome critical region of chromosome 21 (chromosome 16 in the mouse), where an increase from diploid to triploid gene dosage has also been suggested as a possible contributor to Down's syndrome-associated megakaryocytic leukemia 4 . However, oncogenesis is obviously not the normal function of Erg in vivo. During embryonic development, Erg expression is associated with mesoderm and particularly with developing endothelium and cartilage, where it seems to have a specific function in the regulation of endothelial genes 5, 6 and chondrocyte genes 7 . In hematopoiesis, Erg has been linked mainly to megakaryocytic gene expression 4 , although its expression pattern, including that in stem cells, T cell precursors and B cell precursors, has hinted at a broader function. However, the mutations available to assess such a function have so far been mainly oncogenic translocations, for which the gain of abnormal function complicates the effects of any loss of normal function.
Structurally, Erg is very similar to another N E W S A N D V I E W S
